Farid Adrienne, Chief Operations Officer at Century Therapeutics ($IPSC), made two open market sales of company shares in the last year, totaling about $907. Her most recent sale occurred on June 9, 2025. These transactions rank 11,551st out of 11,678 insiders in our database, well below the average sale amount of 8.6 million across 6.4 transactions per insider. Farid Adrienne recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 9, 2025 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 552 | $0.62 | 250,141.0000 | 86,098,619 | 0.22% | 0.00% |
| May 5, 2025 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1024 | $0.55 | 250,693.0000 | 86,098,619 | 0.41% | 0.00% |
| March 10, 2025 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 2359 | $0.62 | 131,717.0000 | 78,648,958 | 1.76% | 0.00% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | A | Common Stock | 120000 | $0.00 | 251,717.0000 | 78,648,958 | 91.10% | 0.15% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 78,648,958 | 9999.99% | 0.15% |
| Feb. 3, 2025 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1054 | $0.78 | 134,076.0000 | 78,648,958 | 0.78% | 0.00% |
| Nov. 4, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1033 | $1.23 | 135,130.0000 | 84,704,352 | 0.76% | 0.00% |
| Aug. 5, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1073 | $1.83 | 136,163.0000 | 82,092,167 | 0.78% | 0.00% |
| May 3, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 913 | $3.11 | 137,236.0000 | 62,296,637 | 0.66% | 0.00% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | A | Common Stock | 24000 | $0.00 | 138,149.0000 | 59,314,389 | 21.03% | 0.04% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | A | Stock Option (right to buy) | 146000 | $0.00 | 146,000.0000 | 59,314,389 | 9999.99% | 0.25% |
| March 6, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | M | Common Stock | 30684 | $1.03 | 144,833.0000 | 59,314,389 | 26.88% | 0.05% |
| March 6, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 30684 | $4.96 | 114,149.0000 | 59,314,389 | 21.19% | 0.05% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | M | Common Stock | 22831 | $1.03 | 136,980.0000 | 59,314,389 | 20.00% | 0.04% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 22831 | $5.14 | 114,149.0000 | 59,314,389 | 16.67% | 0.04% |
| March 6, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | M | Stock Option (right to buy) | 30684 | $0.00 | 191,486.0000 | 59,314,389 | 13.81% | 0.05% |
| March 7, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | M | Stock Option (right to buy) | 22831 | $0.00 | 168,655.0000 | 59,314,389 | 11.92% | 0.04% |
| Feb. 16, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | M | Common Stock | 485 | $1.03 | 114,634.0000 | 59,314,389 | 0.42% | 0.00% |
| Feb. 16, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 485 | $4.86 | 114,149.0000 | 59,314,389 | 0.42% | 0.00% |
| Feb. 16, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | M | Stock Option (right to buy) | 485 | $0.00 | 222,170.0000 | 59,314,389 | 0.22% | 0.00% |
| Feb. 5, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 2035 | $3.84 | 115,933.0000 | 59,314,389 | 1.73% | 0.00% |
| Feb. 6, 2024 | Century Therapeutics, Inc. | $IPSC | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1784 | $4.49 | 114,149.0000 | 59,314,389 | 1.54% | 0.00% |